Ambien and Hysingla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ambien (zolpidem tartrate) and Hysingla (hydrocodone bitartrate). Common drug interactions include rheumatoid arthritis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Ambien and Hysingla. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Ambien?

Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 93,519 Ambien users. Check the latest studies of Ambien.

What is Hysingla?

Hysingla has active ingredients of hydrocodone bitartrate. eHealthMe is studying from 32,609 Hysingla users. Check the latest studies of Hysingla.



On Jul, 09, 2026

41 people who take Ambien and Hysingla together, and have interactions are studied.

Ambien and Hysingla drug interactions.

What are the common drug interactions of Ambien and Hysingla, by gender? *:

female:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Drug ineffective
  3. Blindness
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Drug dependence
  6. Gastric ulcer (stomach ulcer)
  7. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  8. Sinusitis (inflammation of sinus)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Vision blurred

male:

  1. Anxiety
  2. Decreased appetite
  3. Back pain
  4. Blood cholesterol increased
  5. Depression
  6. Drug dependence
  7. Muscle tightness
  8. Neck pain
  9. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  10. Benign prostatic hyperplasia (benign enlargement of the prostate)

What are the common drug interactions of Ambien and Hysingla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Aphasia (damage to the parts of the brain that control language)
  3. Blood pressure increased
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Decreased appetite
  6. Dependence
  7. Drug dependence
  8. Drug ineffective
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Dry mouth

50-59:

  1. Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
  2. Sinusitis (inflammation of sinus)
  3. Vision blurred
  4. Drug ineffective
  5. Blindness unilateral
  6. Immunodeficiency
  7. Blindness
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Depression
  3. Fatigue (feeling of tiredness)
  4. Arthralgia (joint pain)
  5. Diarrhoea
  6. Nausea (feeling of having an urge to vomit)
  7. Respiration (transport of oxygen from the outside air to the cells within tissues)
  8. Thrombosis (formation of a blood clot inside a blood vessel)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 46.34%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 19 people, 46.34%
  3. Drowsiness: 7 people, 17.07%
  4. Pain: 6 people, 14.63%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 12.20%
  6. Stress And Anxiety: 3 people, 7.32%
  7. Sleep Disorder: 3 people, 7.32%
  8. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Ambien and Hysingla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ambien and Hysingla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ambien:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hysingla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambien and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hysingla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate and hydrocodone bitartrate (the active ingredients of Ambien and Hysingla, respectively), and Ambien and Hysingla (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: